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Abstract 
 
Background: Malaria infections cause various symptoms ranging from asymptomatic infections to severe disease 
complications. Plasmodium vivax malaria has been recognized as a disease that attacks blood cells, causing various 
hematologic changes, especially anemia, leukopenia, leukocytosis, neutropenia, neutrophilia, and thrombocytopenia 
with different percentages. Plasmodium vivax, formerly known to cause mild malaria, was later proven to cause 
severe malaria, even cerebral malaria such as Plasmodium falciparum. This study aims to determine the hematologic 
profile in patients with Plasmodium vivax malaria.  
Method: This research use descriptive cross sectional design. This research was conducted in Puskesmas (PKM; 
Primary Health Care) Sukamaju and Puskesmas (PKM; Primary Health Care) Karang City in August until 
December 2017. Samples were taken by consecutive sampling. A total of 37 samples expressed  positive 
Plasmodium vivax, examined their hematologic profiles specifically hemoglobin, erythrocytes, leucocytes, platelets, 
lymphocytes, neutrophils, monocytes and hematocrit using automatic hematology cell counter.  
Results: Based on the results of this study, 56.76% of patients had anemia, 45.90% of patients had  leukopenia, 
89.20% thrombocytopenia, 2.70% neutrophilia, 10.80% neutropenia, 2.70% lymphocytosis, 35.10% lymphopenia, 
and 13.50% pancytopenia.  
Conclusion: In patients with Plasmodium vivax malaria infection there may be a change in hematologic profiles, 
this change may be affected by the acute phase of infection and host immune system. 
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Background 
Malaria remains a health problem worldwide, with an average of 300-500 million cases 
each year and nearly one million death.1 Malaria affects almost all regions of the world, but 
malaria is endemic in the tropics to the subtropics region namely Asia, Africa, Central and South 
America. Based on the World Health Organization (WHO) report, the number of malaria cases 
worldwide from 2000 to 2015 was 212 million cases. By 2015, there are 174 million people in 
the world are at risk of developing malaria. Most malaria cases (90%) are in Africa, 7% in 
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Southeast Asia, and 2% in the Mediterranean region.2 There are five species of malaria that 
infect humans: Plasmodium falciparum, Plasmodium  ovale, Plasmodium  malariae, 
Plasmodium vivax, and Plasmodium knowlesi. Among the four species, Plasmodium falciparum 
and Plasmodium vivax are the highest prevalence of malaria in the world. Although Plasmodium 
falciparum is the most common cause of malaria associated with high mortality rates, 
geographically, Plasmodium vivax has a widespread distribution.3 Most cases of malaria 
occurring in Southeast Asia are caused by Plasmodium vivax which is 58% of cases. In addition, 
there are four countries with the main causes of malaria is Plasmodium vivax namely Ethiopia, 
India, Indonesia and Pakistan.2 
Malaria infections cause a variety of symptoms ranging from asymptomatic infections to 
severe disease complications.4 Plasmodium vivax malaria has been recognized as a disease that 
attacks blood cells, causing various hematological changes, especially anemia, leukopenia, 
leukocytosis, neutropenia, neutrophilia, and thrombocytopenia with different percentages.5,6,7,8 
Plasmodium vivax previously known to cause mild malaria, was later proven to cause severe 
malaria, even cerebral malaria such as Plasmodium falciparum.5,9,10 
 
Methods 
The type of this research is descriptive with cross sectional study design. This research 
has been conducted in August until December 2017. Blood sampling is done at Puskesmas 
Karang City and Puskesmas Sukamaju Bandar Lampung by consecutive sampling. Examination 
of the number of neutrophils conducted at the Central Laboratory of Lampung. Patients taken 
were confirmed patients infected with P. vivax by microscopic examination, aged 6 years or 
older and willing to be the subject of the study and sign the informed consent. Patients receiving 
mixed infection of Plasmodium vivax with other Plasmodium while in pregnancy, having chronic 
infections, such as tuberculosis, dengue disease, mumps, or measles, having a history of 
autoimmune disease and a history of malignant disease, and taking anti-inflammatory drugs, 
Isoniazid, and quinine is excluded this. The number of samples obtained according to inclusion 
and exclusion criteria was 37 samples. 
Samples taken according to inclusion and exclusion criteria through anamnesis include 
symptoms experienced, history of previous illness and history of drug consumption. Blood 
samples were taken in the right or left arm cubital fossa (basilica vein/ cephalic vein/medial 
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cubital vein) of 3 cc. The blood samples were subjected to a process of peripheral blood 
examination to confirm the type of malaria and laboratory examination for hematologic 
examination specifically hemoglobin, erythrocytes, leukocytes, thrombocytes, lymphocytes, 
neutrophils, monocytes and hematocrit using automatic hematology cell counter equipment in 
the Clinical Pathology Laboratory of UPTD (Unit Pelayanan Tranfusi Darah; Blood Transfusion 
Service Unit) Laboratory Hall Health of Lampung Province. The process of sending samples 
from the collection point to the checkpoint used a cooler at 4°C. 
 
Results 
Of the 37 respondents obtained, the majority are male (64.9%) and the age of most respondents 
was 26-45 years (48.6%). A total of 78.4% of respondents are indigenous. Based on history of 
malaria infection, 62.2% of new respondents were first infected with malaria. From 37 samples 
of blood of respondents examined hematologic profile obtained the average hemoglobin, 
leukocyte, erythrocytes, lymphocyte, monocyte, neutrophil and hematocrit have normal values 
and only slightly decreased thrombocyte value from the normal value of 104.21 ± 63.46 103/μL. 
However, when the result of hematologic profile of each individual, 56.76% of patients had 
anemia, 45,90% of patients had  leukopenia, 89.20% with thrombocytopenia, 2.70% 
neutrophilia, 10.80% neutropenia, 2.70% lymphocytosis , 35.10% of lymphopenia, and 13.50% 
of pancytopenia. The hematologic profile of Plasmodium vivax malaria patients is presented in 
Table 1 and Table 2. 
 
Table 1 Average Amount of Hematologic Profile of Malaria Plasmodium vivax Patients 
Parameter N Mean ± SD 
Hemoglobin (g/dL) 37 12,8 ± 2,14 
Leukocyte (103/µL) 37 5,548 ± 1,71 
Erythrocyte (million/ µL) 37 4,600 ± 0,78 
Thrombocyte (103/µL) 37 104,21 ± 63,46 
Lymphocyte (/µL) 37 1366,21 ± 770,09 
Monocyte (/µL) 37 365,67 ± 179,1 
Neutrophil (/µL) 37 3810,81 ± 1485,8 
Hematocrit (%) 37 39,10 ± 6,82 
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Table 2 Hematologic Profile of Malaria Plasmodium vivax Patients 
Parameter Frequency Percentage (%) 
Anemia 
• Male 
• Female 
Total 
 
14 
 7 
21 
 
58,30 
53,80 
56,76 
Leucopenia 17 45,90 
Thrombocytopenia 33 89,20 
Neutrophilia 
Neutropenia 
 1 
 4 
  2,70 
10,80 
Lymphocytosis 
Lymphopenia 
 1 
13 
  2,70 
35,10 
Pancytopenia  5 13,50 
 
Discussion 
Based on the data, characteristic of the majority respondents are male (64.9%). The result 
of this research is almost the same with the result of a research conducted by Manas et. al (2017) 
that most of the respondents of malaria are male (64,1%). This can be happened because men are 
more likely to be in or working in malaria endemic areas such as miners, forest workers and 
fishermen.11 
In this study obtained from 37 patients there were 56.76% of patients experiencing 
anemia. Research conducted by other researchers also showed similar results.7,8 The 
pathogenesis of anemia in malaria patients is complex, anemia may arise due to an imbalance 
between production and the destruction of red blood cells due to hemolysis, erythrocyte 
sequestration, and ineffective erythropoiesis due to high levels of TNF α in circulation.12,13 
Increased destruction of these erythrocytes can be caused by parasitic hemoglobin digestion, 
parasitized red blood cell destruction (PRBC) during the schizogonic phase, and the destruction 
of the erythrocyte membrane. While the reduction in erythrocyte production may be due to 
suppression of erythropoiesis due to the production of excessive pro-inflammatory cytokines and 
diseritropoiesis.12 
In this study also found the presence of thrombocytopenia as much as 89.20%. 
Thrombocytopenia is a hematological change that is common in acute malaria. 
Thrombocytopenia in malaria can be caused by several factors including increased platelet 
pooling in the spleen due to splenomegaly, platelet activation and aggregation, platelet 
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phagocytosis, platelet adhesion to erythrocytes, oxidative stress leading to premature platelet 
death and hyper-reactive malaria splenomegaly (HMS).14,15 
Another hematological parameter that undergoes a change in this study was leukocytes, 
as many as 17 patients (45.90%) had leukopenia. Leukocytes play an important role in the body's 
defense against malaria. Changes in leukocytes in malaria patients are influenced by many 
factors such as the acute phase of malaria, parasitemia, severity of the disease, immune status of 
the host against malaria and other infections.16 
Based on the results of this study obtained the average result of the number of neutrophils 
is normal that is 3810.81 ± 1485.8/μl. Of 37 patients, 86.5% of normal neutrophils were found, 
10.8% neutropenia and 2.7% neutrophilia. In malaria patient there is a change in hematologic 
parameters of neutrophils that may be neutropenia or neutrophilia, but the most common 
netropenia.12,17,18 The average number of neutrophils in malaria infection depends on the phase 
of infection. Neutrophil activation occurs early in the malaria infection. In the acute phase the 
number of neutrophils will increase and return to normal during the convalescent phase. This is 
due to the acceleration of the production and or the release of neutrophils into the circulation.19,20 
Neutrophilia in malaria can be caused by the circulating pooling mechanism from circulation 
pools to an enlarged marginated pool due to infection so that the number of circulating 
neutrophils in the malaria patient is reduced, spleen activity during infection, lymphotoxic serum 
factor and neutrophil sequestration due to increased expression of cell adhesion molecules 
(ICAM-1 and VCAM-1) in malaria.21,22,23 Neutrophilia in malaria patients is usually found in 
severe malaria or secondary infection by bacteria.24 The number of neutrophils in the blood is 
maintained in a stable amount through the process of hematopoiesis in the bone marrow, the 
neutrophil distribution from the marginated pool to the blood and the number of neutrophils 
coming out of the blood into the tissues. After entering the circulation, the neutrophil half-life is 
only 6 to 8 hours.25 The production of neutrophils in the bone marrow is regulated by three major 
glycoprotein or cytokine hormones, namely interleukin-3 (IL-3), granulocyte-Monocyte Colony 
Stimulating Factor, and Granulocyte Colony-Stimulating Factor (G-CSF).26 Granulocyte Colony-
Stimulating Factor (G-CSF) is a predominant factor of regulation of the neutrophil life cycle by 
increasing cell proliferation, cell survival, differentiation, and neutrophil cell mobilization.27 
As with neutrophils, the number of lymphocytes in malaria patients may be decreased, 
normal or increased in acute malaria.28 In this study, the average number of normal lymphocytes 
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was 1366,21 ± 770,09/μl. Of 37 patients, 35.10% of patients had lymphopenia and 2.70% 
lymphocytosis. Lymphopenia can occur due to redistribution of lymphocytes to tissues from the 
circulating pool to the marginated pool and the destruction of lymphocytes due to Fas-induced 
apoptosis.21,29,30 
The condition of pancytopenia was also found in this study, as many as 5 patients 
(13.5%), in accordance with previous studies, showing pancytopenia in malaria P. vivax as much 
as 17.1% and 13.68%.7,8 Suspected occurrence of pancytopenia in malaria infection is caused by 
the hemophagocytosis syndrome.12 This result proves that a single infection of P. vivax can cause 
pancytopenia as well as P. falciparum. 
 
Conclusion 
In patients with Plasmodium  vivax malaria there may be a change in hematologic profile. 
Many factors that affect it include the phase of malaria infection and host immune system. 
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